L‑Dex® Analysis
Lymphedema (cancer survivorship)
CommercialActive
Key Facts
About ImpediMed
Australian med‑tech firm delivering FDA‑cleared BIS diagnostics for fluid‑status monitoring across oncology, cardiology and metabolic care.
View full company profile